Hemofília: vizsgálatok itt: Olaszország
23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- Where
- Milan, Rozzano
- Életkor
- 2 év to 59 év
- People
- 60 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05987449 · EU 2023-503906-35-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Florence, Milan, Naples, Rome, Rozzano
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Florence, Milan, Naples, Padova
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Florence, Milan, Padova, Rozzano
- Életkor
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460 · EU 2025-521858-42-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Genoa, Milan, Parma, Rome, Rozzano, Turin
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - No phaseTaking peopleAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
- Where
- Many Locations
- Életkor
- 7 év to 12 év
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Florence, Milan, Naples, Rome, Rozzano
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peopleA Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
- Where
- Napoli
- Életkor
- 18 év to 64 év
- People
- 32 worldwide
- Run by
- Pfizer Inc.
See details and how to join2025-523660-21-00 · EU 2025-523660-21-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Where
- Florence, Genoa, Milan, Rome, Rozzano, Vicenza
- Életkor
- 2 év and over
- People
- 130 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06379789 · EU 2023-507260-40-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Genoa, Parma, Rome, Rozzano, Turin
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - No phaseTaking peopleIdentification of New Biomarkers in Haemophilic Arthropathy Through Transcriptome Analysis
- Where
- Milan
- People
- 20
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07867821 - No phaseTaking peopleTight Control of Treatment Adherence and Efficacy by Telemedicine for an Improved Personalized Management of Patients With Hemophilia
- Where
- Milan
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07867834 - 4. fázisTaking peopleA Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Where
- Milan, Rozzano
- Életkor
- 12 év and over
- People
- 20 worldwide
- Run by
- Sanofi
See details and how to joinNCT06145373 · EU 2022-502414-84-00 - 1. fázisTaking peopleA Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
- Where
- Florence
- Életkor
- 18 év and over
- People
- 21 worldwide
- Run by
- Tiumbio Co. Ltd.
See details and how to join2024-511814-20-00 · EU 2024-511814-20-00 - 1. fázisTaking peopleA Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Florence, Naples
- Életkor
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00 - 4. fázisTaking peopleNuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Catanzaro, Palermo, Trento
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00 · EU 2022-502061-17-00 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome, Torino, Turin
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - 4. fázisTaking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Catanzaro, Florence, Milan
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - 4. fázisTaking peopleNuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Catanzaro, Palermo
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580 - 4. fázisCsak meghívásosA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseCsak meghívásosA Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
- Where
- Parma, Roma, Torino, Vicenza
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04574076 - 4. fázisTaking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Catanzaro, Florence, Rozzano
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00 · EU 2022-502060-21-00 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Florence, Genova, Milan
- People
- 4000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119